1
|
Abstract
Nebulizers generate aerosols from liquid-based solutions and suspensions. Nebulizers are particularly well suited to delivering larger doses of medication than is practical with inhalers and are used with a broad range of liquid formulations. When the same drug is available in liquid or inhaler form, nebulizers are applicable for use with patients who will not or cannot reliably use a pressurized metered-dosed inhaler (pMDI) or dry powder inhaler (DPI) due to poor lung function, hand-breath coordination, cognitive abilities (e.g., infants, elderly) or device preference. In a nebulizer, liquid medication is placed in a reservoir and fed to an aerosol generator to produce the droplets. A series of tubes and channels direct the aerosol to the patient via an interface such as mouthpiece, mask, tent, nasal prongs or artificial airway. All nebulizers contain these basic parts, although the technology and design used can vary widely and can result in significant difference in ergonomics, directions for use, and performance. While many types of nebulizers have been described, the three categories of modern clinical nebulizers include: (1) pneumatic jet nebulizers (JN); (2) ultrasonic nebulizers (USN); and (3) vibrating mesh nebulizers (VMN). Nebulizers are also described in terms of their reservoir size. Small volume nebulizers (SVNs), most commonly used for medical aerosol therapy, can hold 5 to 20 mL of medication and may be jet, ultrasonic, or mesh nebulizers. Large volume nebulizers, typically jet or ultrasonic nebulizers, hold up to 200 mL and may be used for either bland aerosol therapy or continuous drug administration.
Collapse
|
2
|
Chweich H, Idrees N, Rideout J, Barnewolt B, Rice L, Hill NS. Randomized Controlled Trial Assessing a Vibrating Mesh Nebulizer Compared to a Jet Nebulizer in Severe Asthma Exacerbations. Respir Care 2024; 69:345-348. [PMID: 37816543 PMCID: PMC10984592 DOI: 10.4187/respcare.10980] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/12/2023]
Affiliation(s)
- Haval Chweich
- Drs Chweich and Hill are affiliated with Division of Pulmonary, Critical Care and Sleep Medicine, Internal Medicine, Tufts Medical Center, Boston, Massachusetts. Dr Idrees is affiliated with Division of Nephrology, Internal Medicine, Boston Medical Center, Boston, Massachusetts. Drs Rideout, Barnewolt, and Rice are affiliated with Department of Emergency Medicine, Tufts Medical Center, Boston, Massachusetts
| | - Najia Idrees
- Drs Chweich and Hill are affiliated with Division of Pulmonary, Critical Care and Sleep Medicine, Internal Medicine, Tufts Medical Center, Boston, Massachusetts. Dr Idrees is affiliated with Division of Nephrology, Internal Medicine, Boston Medical Center, Boston, Massachusetts. Drs Rideout, Barnewolt, and Rice are affiliated with Department of Emergency Medicine, Tufts Medical Center, Boston, Massachusetts
| | - Jesse Rideout
- Drs Chweich and Hill are affiliated with Division of Pulmonary, Critical Care and Sleep Medicine, Internal Medicine, Tufts Medical Center, Boston, Massachusetts. Dr Idrees is affiliated with Division of Nephrology, Internal Medicine, Boston Medical Center, Boston, Massachusetts. Drs Rideout, Barnewolt, and Rice are affiliated with Department of Emergency Medicine, Tufts Medical Center, Boston, Massachusetts
| | - Brien Barnewolt
- Drs Chweich and Hill are affiliated with Division of Pulmonary, Critical Care and Sleep Medicine, Internal Medicine, Tufts Medical Center, Boston, Massachusetts. Dr Idrees is affiliated with Division of Nephrology, Internal Medicine, Boston Medical Center, Boston, Massachusetts. Drs Rideout, Barnewolt, and Rice are affiliated with Department of Emergency Medicine, Tufts Medical Center, Boston, Massachusetts
| | - Lauren Rice
- Drs Chweich and Hill are affiliated with Division of Pulmonary, Critical Care and Sleep Medicine, Internal Medicine, Tufts Medical Center, Boston, Massachusetts. Dr Idrees is affiliated with Division of Nephrology, Internal Medicine, Boston Medical Center, Boston, Massachusetts. Drs Rideout, Barnewolt, and Rice are affiliated with Department of Emergency Medicine, Tufts Medical Center, Boston, Massachusetts
| | - Nicholas S Hill
- Drs Chweich and Hill are affiliated with Division of Pulmonary, Critical Care and Sleep Medicine, Internal Medicine, Tufts Medical Center, Boston, Massachusetts. Dr Idrees is affiliated with Division of Nephrology, Internal Medicine, Boston Medical Center, Boston, Massachusetts. Drs Rideout, Barnewolt, and Rice are affiliated with Department of Emergency Medicine, Tufts Medical Center, Boston, Massachusetts.
| |
Collapse
|
3
|
Abstract
INTRODUCTION Nebulizers are the oldest modern method of delivering aerosols to the lungs for the purpose of respiratory drug delivery. While use of nebulizers remains widespread in the hospital and home setting, certain newer nebulization technologies have enabled more portable use. Varied fundamental processes of droplet formation and breakup are used in modern nebulizers, and these processes impact device performance and suitability for nebulization of various formulations. AREAS COVERED This review first describes basic aspects of nebulization technologies, including jet nebulizers, various high-frequency vibration techniques, and the use of colliding liquid jets. Nebulizer use in hospital and home settings is discussed next. Complications in aerosol droplet size measurement owing to the changes in nebulized droplet diameters due to evaporation or condensation are discussed, as is nebulization during mechanical ventilation. EXPERT OPINION While the limelight may often appear to be focused on other delivery devices, such as pressurized metered dose and dry powder inhalers, the ease of formulating many drugs in water and delivering them as aqueous aerosols ensures that nebulizers will remain as a viable and relevant method of respiratory drug delivery. This is particularly true given recent improvements in nebulizer droplet production technology.
Collapse
Affiliation(s)
- Andrew R Martin
- University of Alberta, Department of Mechanical Engineering , Edmonton, Alberta, T6G 2G8 , Canada
| | | |
Collapse
|
4
|
Boukhettala N, Porée T, Diot P, Vecellio L. In vitro performance of spacers for aerosol delivery during adult mechanical ventilation. J Aerosol Med Pulm Drug Deliv 2014; 28:130-6. [PMID: 25050644 DOI: 10.1089/jamp.2013.1091] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
BACKGROUND During mechanical ventilation, different aerosol generators are employed with various interfaces. The objective of this study was to evaluate the performance of a range of spacers, including a new device called Combihaler® designed for connection with both nebulizers and pressurized Metered-Dose Inhalers (pMDIs). METHODS To assess the spacers, we used a ventilator and the Dual Adult Training and Test Lung (model 5600i, Michigan Instruments). Ventilation parameters were measured with and without spacers in volume-controlled and pressure-controlled mode. A filter was placed at the end of the endotracheal tube to measure aerosol delivery. Amikacin (1 g/8 mL) and salbutamol (5 mg/5 mL) were nebulized with an Aeroneb Solo® connected to its T-adapter or the Combihaler® spacer. Salbutamol (100 μg/actuation with 10 actuations) and beclomethasone (250 μg/actuation with 10 actuations) were delivered with a pMDI connected to a Minispacer®, an ACE® spacer, or a Combihaler® spacer. Drug delivery measurements were performed in volume-controlled mode in dry and humidified conditions. Drug deposits on the filter were assayed. RESULTS The use of spacers and the T-adapter did not change the ventilation parameters (p>0.9). Aerosol delivery of salbutamol and Amikacin by nebulization increased up to three-fold with the Combihaler® compared with the T-adapter in humidified and nonhumidified conditions (p<0.05). Aerosol delivery of salbutamol and beclometasone by pMDI increased up to three-fold with the Combihaler® and the ACE® spacer compared with the Minispacer® in humidified and nonhumidified conditions (p<0.05). Aerosol delivery by pMDIs and vibrating mesh nebulizers using either a T-adapter or spacers was reduced by up to 62.5% in a humidified circuit compared with a nonhumidified circuit. CONCLUSION Aerosol delivery via pMDIs and vibrating mesh nebulizers is greater with large spacers (Combihaler® and ACE®) than with smaller spacers (Minispacer®) or a T-adapter, in both humidified and nonhumidified conditions. In humidified conditions, the aerosol delivery decreased with all spacers.
Collapse
Affiliation(s)
- Nabile Boukhettala
- 1 Centre d'Etude des Pathologies Respiratoires INSERM, Université François Rabelais de Tours , F-37032 Tours, France
| | | | | | | |
Collapse
|